The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Exudative macular degeneration and intravitreal triamcinolone A pilot study
Open accessAbstract
Purpose: To study the efficacy of the anti‐inflammatory agent triamcinolone (Kenacort A‐40) in patients with exudative age‐related macular degeneration and subfoveal and juxtafoveal choroidal new vessels, considered unsuitable for laser photocoagulation. Method: Thirty eyes of 28 patients were treated with intravitreal injection of triamcinolone. The subsequent visual acuity (VA) of treated eyes was compared with published VA outcomes of untreated eyes. Patients were classified into three types according to their responses to treatment. Results: Within two weeks of receiving treatment, exudation decreased and vision improved in the majority of Types I and II patients (87%), the trend continuing in longer term follow‐up. The overall VA outcome for treated eyes was significantly better than published VA data for untreated exudative macular lesions. Conclusions:The preliminary results are encouraging and no serious side effects of a single injection of triamcinolone have been detected in patients followed for up to 18 months. The treatment should, however, continue to be regarded as unproven and only administered in the context of a prospective, case‐controlled clinical trial.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Penfold, P. L., Provis, J. M., & Billson, F. A. (1987) · Graefes Archive for Clinical and Experimental Ophthalmology · doi:10.1007/bf02155808 · Cited by 108
Self-citation
Cited by
RISKS OF INTRAVITREOUS INJECTION: A COMPREHENSIVE REVIEW
JAGER, R. D., AIELLO, L. P., PATEL, S. C., & CUNNINGHAM, E. T. (2004) · Retina · doi:10.1097/00006982-200410000-00002 · Cited by 572
Immunological and Aetiological Aspects of Macular Degeneration
Penfold, P. L., Madigan, M. C., Gillies, M. C., & Provis, J. M. (2001) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(00)00025-2 · Cited by 460
Self-citationIntraocular pressure after intravitreal injection of triamcinolone acetonide
Jonas, J. B. (2003) · British Journal of Ophthalmology · doi:10.1136/bjo.87.1.24 · Cited by 422
Exudative macular degeneration and intravitreal triamcinolone: 18 month follow up
Challa, J. K., Gillies, M. C., Penfold, P. L., Gyory, J. F., Hunyor, A. B., & Billson, F. A. (1998) · Australian and New Zealand Journal of Ophthalmology · doi:10.1111/j.1442-9071.1998.tb01330.x · Cited by 324
Self-citationIntraocular Pressure Elevation After Intravitreal Triamcinolone Acetonide Injection
JONAS, J., DEGENRING, R., KREISSIG, I., AKKOYUN, I., & KAMPPETER, B. (2005) · Ophthalmology · doi:10.1016/j.ophtha.2004.10.042 · Cited by 323
Metadata
- Authors
- Penfold, P. L., Gyory, J. F., Hunyor, A. B., & Billson, F. A.
- Venue
- Australian and New Zealand Journal of Ophthalmology
- Publisher
- Wiley
- Published
- 1995-11
- Volume
- 23
- Issue
- 4
- Pages
- 293-298
- ISSN
- 0814-9763 (ISSN-L)
- 1440-1606
- OpenAlex
- W1994515616
- Cited by
- 221
- References
- 1
- FWCI
- 2.61
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Exudative macular degeneration and intravitreal triamcinolone A pilot study. https://app.cochat.ai/papers/10.1111/j.1442-9071.1995.tb00179.x
- The paper
- Penfold, P. L., Gyory, J. F., Hunyor, A. B., & Billson, F. A. (1995). Exudative macular degeneration and intravitreal triamcinolone A pilot study. Australian and New Zealand Journal of Ophthalmology. https://doi.org/10.1111/j.1442-9071.1995.tb00179.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
